BIOPX
Get informed when a big investor buys or sells
+ Follow| Market cap | $4.22 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $2.29 (3.51%) |
| Earnings per Share | $- |
| Beta | 1.27 |
| Outstanding Shares | - |
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
The fund aims for long-term growth primarily through investments in common stock, focusing on mid-sized U.S. companies with growth potential. BAMCO, Inc., acting as the Adviser, outlines its criteria for "mid-sized companies" at the time...